f-chemotactic peptide has been researched along with cycloheximide in 1 studies
| Studies (f-chemotactic peptide) | Trials (f-chemotactic peptide) | Recent Studies (post-2010) (f-chemotactic peptide) | Studies (cycloheximide) | Trials (cycloheximide) | Recent Studies (post-2010) (cycloheximide) |
|---|---|---|---|---|---|
| 79 | 0 | 4 | 19,109 | 6 | 861 |
| Protein | Taxonomy | f-chemotactic peptide (IC50) | cycloheximide (IC50) |
|---|---|---|---|
| COUP transcription factor 2 isoform a | Homo sapiens (human) | 1.315 | |
| Glucose transporter | Leishmania mexicana | 0.242 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.31 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.228 | |
| Eukaryotic initiation factor 4A-I | Homo sapiens (human) | 0.139 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 3.6 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.036 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ainsworth, T; Mathison, JC; Omidi, S; Simon, S; Sklar, LA; Tobias, PS; Ulevitch, RJ; Weingarten, R | 1 |
1 other study(ies) available for f-chemotactic peptide and cycloheximide
| Article | Year |
|---|---|
Interactions of lipopolysaccharide with neutrophils in blood via CD14.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Membrane; Cells, Cultured; Cycloheximide; Flow Cytometry; Fluorescent Antibody Technique; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Macrophage-1 Antigen; Neutrophils; Oligopeptides; Receptors, Immunologic; Tumor Necrosis Factor-alpha; Up-Regulation | 1993 |